Transit Scientific”s XO Score Scoring Sheath Platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA). The MDEA is a premier design competition in the medtech industry, recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Recently, the company received European CE Mark […]
Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European Union for treatment of peripheral artery disease and end stage renal disease. Last year, the company announced FDA clearance for the device. We’ve been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our […]
Clene Inc. announced on Monday that the company received a Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine (NAM) to accelerate the preclinical development of CNM-Au8, a bioenergetic nanocatalyst, for treatment of neuronal aging-related deficits and Alzheimer’s disease. The international award will fund preclinical study of CNM-Au8 nanocatalysis for the improvement of human health […]
The Centers for Medicare & Medicaid Services (CMS) has once again delayed the January 14, 2021 final rule to establish the Medicare Coverage of Innovative Technology (MCIT) program. In a rule published in the federal register May 18, CMS further delays the effective date of the program to December 15, 2021. In issuing the rule, […]
ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the company’s TellDx circulating tumor cells (CTCs) technology in several research applications. ARUP has also invested in TellBio as part of the startup’s series A financing round. Other funding partners include Crocker Ventures, Genetron Holdings Ltd (NASDAQ: […]
Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. “Xenter is transforming healthcare as an innovative Device-Data-Drug healthcare technologies startup,” said Kelvyn Cullimore, president and CEO of BioUtah. “The new additions to the board, including Utah life […]
Discussion around drug pricing often raises the issue of just how much NIH funding drives the development of new therapies. The general perception is that NIH funding is largely responsible for the creation and approval of new therapies. However, a new study by VitalTransformation (sponsored by BIO and PhRMA) finds that perception to be misguided. […]
IDbyDNA, the pioneer in precision metagenomics, has appointed Next-Generation Sequencing (NGS) leader Neil Gunn as its new CEO to drive the next phase of the company’s growth. “Having spent the last 12 years growing the PCR and sequencing businesses at Roche, I’m excited by the tremendous potential IDbyDNA’s platform has to transform the diagnostic approach to […]
The House Energy and Commerce Health Subcommittee on Tuesday held a hearing on “Negotiating A Better Deal: Legislation to Lower the Cost of Prescription Drugs.” All committee members called for legislation to lower drug costs, but differed along party line on how best to achieve that. House Democrats recently reintroduced H.R. 3, a sweeping drug pricing […]
This week SINTX Technoloiges announced multiple U.S. and international patent applications for development of new technologies utilizing the company’s silicon nitride. “The innovative application of SINTX’s silicon nitride promises new tools to improve our public health response to COVID-19 and other viruses,” said Kelvyn Cullimore, president and CEO of BioUtah. SINTX has found that its […]
Foldax was named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the most promising private companies in the medical technology industry. “BioUtah congratulates Foldax on this well-deserved recognition, which is all the more impressive amid the challenges of a pandemic,” said Kelvyn Cullimore, president and CEO of BioUtah. Foldax […]
The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement so that any country can produce vaccines without worrying about patent infringement. This has the potential to drastically hinder global vaccine manufacturing and distribution and sets a dangerous precedent for future pandemics. The […]